A phase 1, open-label, controlled clinical trial to evaluate pharmacokinetics after administration of Technosphere insulin inhalation powder alone and with salbutamol (albuterol) and/or after methacholine challenge testing in subjects with asthma versus matched healthy subjects without asthma
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2012
At a glance
- Drugs Insulin; Salbutamol
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors MannKind Corporation
- 12 Jun 2012 Additional trial location (USA) identified as reported by ClinicalTrials.gov.
- 12 Jun 2012 Actual patient number is 30 according to ClinicalTrials.gov.
- 22 May 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.